Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 20, 2020 - Issue 1
Submit an article Journal homepage
238
Views
4
CrossRef citations to date
0
Altmetric
Review

Limited treatment options in refractory multiple myeloma: promising therapeutic developments

Albert OriolHematology Service and Hemato-Oncology Clinical Trial Unit, Institut Català d’Oncologia, Badalona, Barcelona, Spain;Josep Carreras Institute and Germans Trias i Pujol Hospital, Badalona, Barcelona, SpainCorrespondence[email protected]
View further author information
,
Laura AbrilHematology Service and Hemato-Oncology Clinical Trial Unit, Institut Català d’Oncologia, Badalona, Barcelona, Spain;Josep Carreras Institute and Germans Trias i Pujol Hospital, Badalona, Barcelona, SpainView further author information
,
Gladys IbarraHematology Service and Hemato-Oncology Clinical Trial Unit, Institut Català d’Oncologia, Badalona, Barcelona, Spain;Josep Carreras Institute and Germans Trias i Pujol Hospital, Badalona, Barcelona, SpainView further author information
&
Alicia SeninHematology Service and Hemato-Oncology Clinical Trial Unit, Institut Català d’Oncologia, Badalona, Barcelona, Spain;Josep Carreras Institute and Germans Trias i Pujol Hospital, Badalona, Barcelona, SpainView further author information
Pages 31-44 | Received 13 Oct 2019, Accepted 20 Dec 2019, Published online: 03 Jan 2020

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Albert Oriol, Alessandra Larocca, Xavier Leleu, Roman Hajek, Hani Hassoun, Paula Rodríguez-Otero, Agne Paner, Fredrik H. Schjesvold, Joachim Gullbo & Paul G. Richardson. (2020) Melflufen for relapsed and refractory multiple myeloma. Expert Opinion on Investigational Drugs 29:10, pages 1069-1078.
Read now

Articles from other publishers (3)

Huilan Zeng, Yuhua Li & Dong-Hua Yang. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 232 249 .
Chinmay Jani, Harpreet Singh, Alexander Walker, Arashdeep Rupal, Carmen M Perrino, Thomas D Caughey & Prudence Lam. (2021) Pomalidomide induced lupus type hypersensitivity reaction. Current Problems in Cancer: Case Reports 3, pages 100065.
Crossref
Yuhong Wang, Tian Mi, Yiming Li, Weijuan Kan, Gaoya Xu, Jingya Li, Yubo Zhou, Jia Li & Xuefeng Jiang. (2021) Design, synthesis and biological evaluation of thioether-containing lenalidomide and pomalidomide derivatives with anti-multiple myeloma activity. European Journal of Medicinal Chemistry 209, pages 112912.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.